Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: A randomised double blind placebo controlled trial

Journal of Neurology Neurosurgery and Psychiatry

Volumn 69, Issue 2, 2000, Pages 217-221

  Bhakta, Bipin B ^a   Cozens, J Alastair ^b   Chamberlain, M Anne ^a   Bamford, John M ^c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b WOODEND HOSPITAL   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Botulinum toxin; Spasticity; Stroke

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADOLESCENT; ADULT; AGED; ARM; ARTICLE; BODY POSTURE; CAREGIVER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELBOW; FEMALE; FINGER; FLEXOR MUSCLE; GRIP STRENGTH; HUMAN; JOINT FUNCTION; MALE; MUSCLE STRENGTH; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SELF CARE; SPASTICITY; STROKE; WRIST;

ADOLESCENT; ADULT; AGED; ARM; BOTULINUM TOXIN TYPE A; CAREGIVERS; CEREBROVASCULAR ACCIDENT; CHILD; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; FEMALE; HAND STRENGTH; HUMANS; MALE; MIDDLE AGED; MUSCLE SPASTICITY; PAIN MEASUREMENT; RANGE OF MOTION, ARTICULAR; TREATMENT OUTCOME;

EID: 0033926243     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.69.2.217     Document Type: Article

References (20)

1. Bamford JM, Sandercock P, Dennis M, et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-6: methodology, demography, and incident cases of first ever stroke. J Neurol Neurosurg Psychiatry 1988;51:1373-80.
2. Nakayama H, Jorgensen HS, Raaschou HO, et al. Recovery of upper extremity function in stroke patients: the Copenhagen stroke study. Arch Phys Med Rehab 1994;75:394-8.
3. Gowland C. Management of the hemiplegic upper limb in stroke rehabilitation. In: Branstater ME, Basmajan JV, eds. Stroke rehabilitation. Baltimore: Williams and Williams, 1987:217-45.
4. Mayer NH, Esquenazi A, Childers MK. Common patterns of clinical motor dysfunction. Muscle Nerve 1997;(suppl 6):21-35.
5. Blasi J, Chapman ER, Link E, et al. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 1993;365:I60-3.
6. Das TK, Park DM. Effect of treatment with botulinum toxin on spasticity. Postgrad Med J 1989;65:208-10.
7. Hesse S, Friedrich H, Domasch C, et al. Botulinum toxin therapy for upper limb flexor spasticity: preliminary results. J Rehabil Sci 1992;5:98-101.
8. Dunne JW, Heye N, Dunne SL. Treatment of chronic limb spasticity with botulinum toxin A. J Nurol Neurosurg Psychiatry 1995;58:232-5.
9. Bhakta BB, Cozens JA, Bamford JM, et al. Use of botulinum toxin in stroke patients with severe upper limb spasticity. J Neurol Neurosurg Psychiatry 1996;61:30-5.
10. Sampio C, Ferreira JJ, Pinto AA, et al. Botulinum toxin type A for the treatment of arm and hand spasticity in stroke patients. Clinical Rehabilitation 1997;11:3-7.
11. Simpson DM, Alexander DN, O'Brien CF, et al. Botulinum toxin type A in the treatment of upper limb spasticity: a randomised double blind placebo controlled trial. Neurology 1996;46:1306-10.
12. Hesse S, Reiter F, Konrad M, et al. Botulinum toxin type A and short term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomised double blind placebo controlled trial. Clinical Rehabilitation 1998;12:381-8.
13. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67:206-7.
14. Perotto AO,ed. Anatomical guide for the electromyographer: the limbs and trunk. 2nd ed. Springfeld, USA: Thomas, 1980.
15. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. MD Med J 1965;14:61-5.
16. Bhakta BB, Tennant A, Cozens JA, et al. Application of item response theory to measure the disabling effects of severe upper limb spasticity in stroke and the consequent carer burden. Cerebrovascular Dis 1999;9(suppl 1):124.
17. Aids to the examination of the peripheral nervous system. London: Medical Research Council, The Stationery Office, 1976. (Memorandum No 45.)
18. Helliwell P, Howe A, Wright V. Functional assessment of the hand: reproducibility, acceptability and utility of a new system for measuring strength. Ann Rheum Dis 1987;46:203-8.
19. Hesse S, Jahnke MT, Luecke D, et al. Short term electrical stimulation enhances effect of botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett 1995;201:37-40.
20. Pandyan AD, Johnson GR, Price CIM, et al. A review of the properties and limitations of the Ashworth and modified Ashworth scales as measures of spasticity. Clinical Rehabilitation 1999;13:373-83.